Cargando…
Telomerase activity in melanoma and non-melanoma skin cancer
Telomeres are specialized structures consisting of repeat arrays of TTAGGG(n) located at the ends of chromosomes. They are essential for chromosome stability and, in the majority of normal somatic cells, telomeres shorten with each cell division. Most immortalized cell lines and tumours reactivate t...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362177/ https://www.ncbi.nlm.nih.gov/pubmed/10408692 http://dx.doi.org/10.1038/sj.bjc.6690010 |
_version_ | 1782153392929374208 |
---|---|
author | Parris, C N Jezzard, S Silver, A MacKie, R McGregor, J M Newbold, R F |
author_facet | Parris, C N Jezzard, S Silver, A MacKie, R McGregor, J M Newbold, R F |
author_sort | Parris, C N |
collection | PubMed |
description | Telomeres are specialized structures consisting of repeat arrays of TTAGGG(n) located at the ends of chromosomes. They are essential for chromosome stability and, in the majority of normal somatic cells, telomeres shorten with each cell division. Most immortalized cell lines and tumours reactivate telomerase to stabilize the shortening chromosomes. Telomerase activation is regarded as a central step in carcinogenesis and, here, we demonstrate telomerase activation in premalignant skin lesions and also in all forms of skin cancer. Telomerase activation in normal skin was a rare event, and among 16 samples of normal skin (one with a history of chronic sun exposure) 12.5% (2 out of 16) exhibited telomerase activity. One out of 16 (6.25%) benign proliferative lesions, including viral and seborrhoeic wart samples, had telomerase activity. In premalignant actinic keratoses and Bowen's disease, 42% (11 out of 26) of samples exhibited telomerase activity. In the basal cell carcinoma and cutaneous malignant melanoma (CMM) lesions, telomerase was activated in 77% (10 out of 13) and 69% (22 out of 32) respectively. However, only 25% (3 out of 12) of squamous cell carcinomas (SCC) had telomerase activity. With the exception of one SCC sample, telomerase activity in a positive control cell line derived from a fibrosarcoma (HT1080) was not inhibited when mixed with the telomerase-negative SCC or CMM extracts, indicating that, overall, Taq polymerase and telomerase inhibitors were not responsible for the negative results. Mean telomere hybridizing restriction fragment (TRF) analysis was performed in a number of telomerase-positive and -negative samples and, although a broad range of TRF sizes ranging from 3.6 to 17 kb was observed, a relationship between telomerase status and TRF size was not found. © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2362177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23621772009-09-10 Telomerase activity in melanoma and non-melanoma skin cancer Parris, C N Jezzard, S Silver, A MacKie, R McGregor, J M Newbold, R F Br J Cancer Regular Article Telomeres are specialized structures consisting of repeat arrays of TTAGGG(n) located at the ends of chromosomes. They are essential for chromosome stability and, in the majority of normal somatic cells, telomeres shorten with each cell division. Most immortalized cell lines and tumours reactivate telomerase to stabilize the shortening chromosomes. Telomerase activation is regarded as a central step in carcinogenesis and, here, we demonstrate telomerase activation in premalignant skin lesions and also in all forms of skin cancer. Telomerase activation in normal skin was a rare event, and among 16 samples of normal skin (one with a history of chronic sun exposure) 12.5% (2 out of 16) exhibited telomerase activity. One out of 16 (6.25%) benign proliferative lesions, including viral and seborrhoeic wart samples, had telomerase activity. In premalignant actinic keratoses and Bowen's disease, 42% (11 out of 26) of samples exhibited telomerase activity. In the basal cell carcinoma and cutaneous malignant melanoma (CMM) lesions, telomerase was activated in 77% (10 out of 13) and 69% (22 out of 32) respectively. However, only 25% (3 out of 12) of squamous cell carcinomas (SCC) had telomerase activity. With the exception of one SCC sample, telomerase activity in a positive control cell line derived from a fibrosarcoma (HT1080) was not inhibited when mixed with the telomerase-negative SCC or CMM extracts, indicating that, overall, Taq polymerase and telomerase inhibitors were not responsible for the negative results. Mean telomere hybridizing restriction fragment (TRF) analysis was performed in a number of telomerase-positive and -negative samples and, although a broad range of TRF sizes ranging from 3.6 to 17 kb was observed, a relationship between telomerase status and TRF size was not found. © 1999 Cancer Research Campaign Nature Publishing Group 1999-01 1999-09-24 /pmc/articles/PMC2362177/ /pubmed/10408692 http://dx.doi.org/10.1038/sj.bjc.6690010 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Parris, C N Jezzard, S Silver, A MacKie, R McGregor, J M Newbold, R F Telomerase activity in melanoma and non-melanoma skin cancer |
title | Telomerase activity in melanoma and non-melanoma skin cancer |
title_full | Telomerase activity in melanoma and non-melanoma skin cancer |
title_fullStr | Telomerase activity in melanoma and non-melanoma skin cancer |
title_full_unstemmed | Telomerase activity in melanoma and non-melanoma skin cancer |
title_short | Telomerase activity in melanoma and non-melanoma skin cancer |
title_sort | telomerase activity in melanoma and non-melanoma skin cancer |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362177/ https://www.ncbi.nlm.nih.gov/pubmed/10408692 http://dx.doi.org/10.1038/sj.bjc.6690010 |
work_keys_str_mv | AT parriscn telomeraseactivityinmelanomaandnonmelanomaskincancer AT jezzards telomeraseactivityinmelanomaandnonmelanomaskincancer AT silvera telomeraseactivityinmelanomaandnonmelanomaskincancer AT mackier telomeraseactivityinmelanomaandnonmelanomaskincancer AT mcgregorjm telomeraseactivityinmelanomaandnonmelanomaskincancer AT newboldrf telomeraseactivityinmelanomaandnonmelanomaskincancer |